Harnessing the Induction of Cardiomyocyte Proliferation for Cardiac Regenerative Medicine
Related Experiment Video
Updated: Apr 4, 2026
Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
Published on: February 3, 2017
Arun Sharma1, Yuan Zhang, Sean M Wu
1Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, 94305, USA, arun.sharma@stanford.edu.
Insights
Adult cardiomyocytes do not regenerate after heart injury. Researchers are exploring ways to stimulate cell division in human cardiomyocytes, including those derived from stem cells, to improve cardiac repair.
Area of Science:
- Cardiovascular Biology
- Regenerative Medicine
- Stem Cell Science
Background:
- Adult human cardiomyocytes are terminally differentiated with limited regenerative capacity.
- Ischemic injury, such as myocardial infarction, leads to permanent cardiac dysfunction due to the inability of cardiomyocytes to be replaced.
- Current research focuses on reactivating cardiomyocyte proliferation and utilizing stem cell-derived cardiomyocytes for cardiac repair.
Purpose of the Study:
- To investigate methods for reactivating cardiomyocyte mitotic activity.
- To explore the potential of stem cell-derived cardiomyocytes for therapeutic applications.
- To identify novel mechanisms for inducing human cardiomyocyte proliferation.
Main Methods:
- In vitro cell culture systems and in vivo animal models are used to study cardiomyocyte proliferation.
- Human induced pluripotent stem cells are differentiated into cardiomyocytes using chemically defined protocols.
- Stem cell-derived cardiomyocytes are analyzed for their proliferative capacity and potential as a model system.
Main Results:
- Stem cell-derived cardiomyocytes, similar to adult cardiomyocytes, are post-mitotic and have limited expansion potential after differentiation.
- These cells offer a platform for studying factors that induce cell cycle reentry and proliferation in human cardiomyocytes.
- The study highlights the shared characteristic of limited proliferation in both adult and stem cell-derived cardiomyocytes.
Conclusions:
- Understanding the mechanisms that regulate cardiomyocyte cell cycle reentry is crucial for developing regenerative therapies.
- Identifying pathways to induce human cardiomyocyte proliferation could significantly improve cardiac function after injury.
- Stem cell-derived cardiomyocytes serve as a valuable model for discovering pro-proliferative strategies for cardiac regeneration.
Opinion Statement:
Adult human cardiomyocytes are terminally differentiated and have limited capacity for cell division. Hence, they are not naturally replaced following ischemic injury to the heart. As such, cardiac function is often permanently compromised after an event such as myocardial infarction. In recent years, investigators have focused intensively on ways to reactivate cardiomyocyte mitotic activity in both in vitro cell culture systems and in vivo animal models. In parallel, advances in stem cell biology have allowed for the mass production of patient-specific human cardiomyocytes from human-induced pluripotent stem cells. These cells can be produced via chemically defined differentiation of human pluripotent stem cells in a matter of weeks and could theoretically be utilized directly for therapeutic purposes to replace damaged myocardium. However, stem cell-derived cardiomyocytes, like their adult counterparts, are post-mitotic and incapable of large-scale expansion after reaching a certain stage of in vitro differentiation. Due to this shared characteristic, these stem cell-derived cardiomyocytes may provide a platform for studying genes, pathways, and small molecules that induce cell cycle reentry and proliferation of human cardiomyocytes. Ultimately, the discovery of novel mechanisms or pathways to induce human cardiomyocyte proliferation should improve our ability to regenerate adult cardiomyocytes and help restore cardiac function following injury.
